Coronavirus
GSK says tests show Vir antibody drug works against Omicron
GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with US partner Vir has indicated that the drug also works against the new Omicron variant.
Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.
For all the latest headlines follow our Google News channel online or via the app.
Read more:
Moderna exec says company could have Omicron booster ready in March
UAE reports its first case of COVID-19 variant Omicron
Fauci: First US case of COVID-19 omicron variant identified
Also Read
-
Vaccine effectiveness will likely drop against Omicron: Moderna CEO
The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been ... Coronavirus -
Moderna exec says company could have Omicron booster ready in March
Moderna Inc could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for US authorization as soon as March, the ... Coronavirus -
UAE reports its first case of COVID-19 variant Omicron
The UAE’s Ministry of Health detected on Wednesday the first case of the Omicron variant in the country, state news agency WAM reported.The new ... Coronavirus
